Miebo (perfluorohexyloctane ophthalmic solution) — Medica

Initial criteria

• Patient has dry eye disease (examples include dry eye syndrome or keratoconjunctivitis sicca)
• age ≥ 18 years

Reauthorization criteria

• Patient continues to have dry eye disease (examples include dry eye syndrome or keratoconjunctivitis sicca)
• age ≥ 18 years

Approval duration

1 year